818 related articles for article (PubMed ID: 19116938)
1. The combination of the biomarkers urinary C-terminal telopeptide of type II collagen, serum cartilage oligomeric matrix protein, and serum chondroitin sulfate 846 reflects cartilage damage in hemophilic arthropathy.
Jansen NW; Roosendaal G; Lundin B; Heijnen L; Mauser-Bunschoten E; Bijlsma JW; Theobald M; Lafeber FP
Arthritis Rheum; 2009 Jan; 60(1):290-8. PubMed ID: 19116938
[TBL] [Abstract][Full Text] [Related]
2. Association of baseline levels of urinary glucosyl-galactosyl-pyridinoline and type II collagen C-telopeptide with progression of joint destruction in patients with early rheumatoid arthritis.
Garnero P; Gineyts E; Christgau S; Finck B; Delmas PD
Arthritis Rheum; 2002 Jan; 46(1):21-30. PubMed ID: 11817593
[TBL] [Abstract][Full Text] [Related]
3. Diurnal variation of serum and urine biomarkers in patients with radiographic knee osteoarthritis.
Kong SY; Stabler TV; Criscione LG; Elliott AL; Jordan JM; Kraus VB
Arthritis Rheum; 2006 Aug; 54(8):2496-504. PubMed ID: 16868970
[TBL] [Abstract][Full Text] [Related]
4. Urinary type II collagen helical peptide (HELIX-II) as a new biochemical marker of cartilage degradation in patients with osteoarthritis and rheumatoid arthritis.
Charni N; Juillet F; Garnero P
Arthritis Rheum; 2005 Apr; 52(4):1081-90. PubMed ID: 15818703
[TBL] [Abstract][Full Text] [Related]
5. Glucosamine sulfate and cartilage type II collagen degradation in patients with knee osteoarthritis: randomized discontinuation trial results employing biomarkers.
Cibere J; Thorne A; Kopec JA; Singer J; Canvin J; Robinson DB; Pope J; Hong P; Grant E; Lobanok T; Ionescu M; Poole AR; Esdaile JM
J Rheumatol; 2005 May; 32(5):896-902. PubMed ID: 15868627
[TBL] [Abstract][Full Text] [Related]
6. Uncoupling of type II collagen synthesis and degradation predicts progression of joint damage in patients with knee osteoarthritis.
Garnero P; Ayral X; Rousseau JC; Christgau S; Sandell LJ; Dougados M; Delmas PD
Arthritis Rheum; 2002 Oct; 46(10):2613-24. PubMed ID: 12384919
[TBL] [Abstract][Full Text] [Related]
7. Cartilage biomarkers in ankylosing spondylitis: relationship to clinical variables and treatment response.
Kim TH; Stone M; Payne U; Zhang X; Ionescu M; Lobanok T; King L; Poole AR; Inman RD
Arthritis Rheum; 2005 Mar; 52(3):885-91. PubMed ID: 15751093
[TBL] [Abstract][Full Text] [Related]
8. Hormone replacement therapy, calcium and vitamin D3 versus calcium and vitamin D3 alone decreases markers of cartilage and bone metabolism in rheumatoid arthritis: a randomized controlled trial [ISRCTN46523456].
Forsblad d'Elia H; Christgau S; Mattsson LA; Saxne T; Ohlsson C; Nordborg E; Carlsten H
Arthritis Res Ther; 2004; 6(5):R457-68. PubMed ID: 15380045
[TBL] [Abstract][Full Text] [Related]
9. Suggestion of nonlinear or phasic progression of knee osteoarthritis based on measurements of serum cartilage oligomeric matrix protein levels over five years.
Sharif M; Kirwan JR; Elson CJ; Granell R; Clarke S
Arthritis Rheum; 2004 Aug; 50(8):2479-88. PubMed ID: 15334461
[TBL] [Abstract][Full Text] [Related]
10. High serum cartilage oligomeric matrix protein determines the subset of patients with early-stage rheumatoid arthritis with high serum C-reactive protein, matrix metalloproteinase-3, and MRI-proven bone erosion.
Fujikawa K; Kawakami A; Tamai M; Uetani M; Takao S; Arima K; Iwamoto N; Aramaki T; Kawashiri S; Ichinose K; Kamachi M; Nakamura H; Origuchi T; Ida H; Aoyagi K; Eguchi K
J Rheumatol; 2009 Jun; 36(6):1126-9. PubMed ID: 19447929
[TBL] [Abstract][Full Text] [Related]
11. Etanercept exerts beneficial effects on articular cartilage biomarkers of degradation and turnover in patients with ankylosing spondylitis.
Maksymowych WP; Poole AR; Hiebert L; Webb A; Ionescu M; Lobanok T; King L; Davis JC
J Rheumatol; 2005 Oct; 32(10):1911-7. PubMed ID: 16206346
[TBL] [Abstract][Full Text] [Related]
12. Cross sectional evaluation of biochemical markers of bone, cartilage, and synovial tissue metabolism in patients with knee osteoarthritis: relations with disease activity and joint damage.
Garnero P; Piperno M; Gineyts E; Christgau S; Delmas PD; Vignon E
Ann Rheum Dis; 2001 Jun; 60(6):619-26. PubMed ID: 11350852
[TBL] [Abstract][Full Text] [Related]
13. Early elevation in circulating levels of C-telopeptides of type II collagen predicts structural damage in articular cartilage in the rodent model of collagen-induced arthritis.
Oestergaard S; Chouinard L; Doyle N; Smith SY; Tankó LB; Qvist P
Arthritis Rheum; 2006 Sep; 54(9):2886-90. PubMed ID: 16947421
[TBL] [Abstract][Full Text] [Related]
14. Cartilage destruction in collagen induced arthritis assessed with a new biochemical marker for collagen type II C-telopeptide fragments.
Ishikawa T; Nishigaki F; Christgau S; Noto T; Mo J; From N; Minoura K; Hirayama Y; Ohkubo Y; Mutoh S
J Rheumatol; 2004 Jun; 31(6):1174-9. PubMed ID: 15170932
[TBL] [Abstract][Full Text] [Related]
15. Biochemical markers of joint tissue damage increase shortly after a joint bleed; an explorative human and canine in vivo study.
van Vulpen LF; van Meegeren ME; Roosendaal G; Jansen NW; van Laar JM; Schutgens RE; Mastbergen SC; Lafeber FP
Osteoarthritis Cartilage; 2015 Jan; 23(1):63-9. PubMed ID: 25219667
[TBL] [Abstract][Full Text] [Related]
16. Effects of moving training on histology and biomarkers levels of articular cartilage.
Qi C; Changlin H
J Surg Res; 2006 Oct; 135(2):352-63. PubMed ID: 16904690
[TBL] [Abstract][Full Text] [Related]
17. Effects of continuous oral administration of phenylbutazone on biomarkers of cartilage and bone metabolism in horses.
Fradette ME; Céleste C; Richard H; Beauchamp G; Laverty S
Am J Vet Res; 2007 Feb; 68(2):128-33. PubMed ID: 17269876
[TBL] [Abstract][Full Text] [Related]
18. Altered collagen turnover in factor VIII-deficient rats with hemophilic arthropathy identifies potential novel serological biomarkers in hemophilia.
Manon-Jensen T; Karsdal MA; Nielsen LN; Kjelgaard-Hansen M; Vandahl B; Olsen EH; Enoksson M; Roepstorff K
J Thromb Haemost; 2016 Dec; 14(12):2419-2429. PubMed ID: 27681457
[TBL] [Abstract][Full Text] [Related]
19. Increased cartilage type II collagen degradation in patients with osteogenesis imperfecta used as a human model of bone type I collagen alterations.
Rousseau JC; Chevrel G; Schott AM; Garnero P
Bone; 2010 Apr; 46(4):897-900. PubMed ID: 20005316
[TBL] [Abstract][Full Text] [Related]
20. Skeletal unloading induces a full-thickness patellar cartilage defect with increase of urinary collagen II CTx degradation marker in growing rats.
Tomiya M; Fujikawa K; Ichimura S; Kikuchi T; Yoshihara Y; Nemoto K
Bone; 2009 Feb; 44(2):295-305. PubMed ID: 19000792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
